Financials
- Market Capitalization 2.01 B
- Employee 264
- Founded 2003
- CEO Kenneth Galbraith
- Website www.zymeworks.com
- Headquarter Delaware, United States
- FIGI BBG019XSYC89
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-24.38
市销率
18.74
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1994 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +8.10% | +59.78% | 2.04 B USD | ||
| 1997 | ZBIO Zenas BioPharma, Inc. - Common Stock | 31.27 USD | -4.14% | -3.49% | -0.32% | +18.18% | 2.04 B USD | ||
| 2009 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.68 USD | -8.24% | -10.59% | +16.36% | +221.34% | 1.99 B USD | ||
| 2011 | NBTX Nanobiotix S.A. - ADSs | 41.23 USD | -8.70% | +1.25% | +7.88% | +397.35% | 2.00 B USD |